Substance
METHYLPHENIDATE HYDROCHLORIDE
Global reference: every product and company linked to this substance.
- cas: 23655-65-4
- ncit: C646
- rxnorm: 203188
- unii: 4B3SC438HI
ADHANSIA XR · APTENSIO · APTENSIO XR · CONCERTA · EQUASYM · EQUASYM XL · FOQUEST · JORNAY PM · METADATE · METADATE CD · METADATE ER · METHYLIN
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | CONCERTA | Q2 2026 | $146.0M |
| COLLEGIUM PHARMACEUTICAL INC. COMMON STOCK | JORNAY PM | Q2 2026 | $46.1M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (4)
- CONCERTA · JOHNSON & JOHNSON COMMON STOCK
- JORNAY PM · COLLEGIUM PHARMACEUTICAL INC. COMMON STOCK
- METHYLPHENIDATE HYDROCHLORIDE · ANI PHARMACEUTICALS INC.
- RITALIN-SR · NOVARTIS AG COMMON STOCK
Companies holding this asset (8)
- ANI PHARMACEUTICALS INC.
- AMNEAL PHARMACEUTICALS INC. CLASS A COMMON STOCK
- COLLEGIUM PHARMACEUTICAL INC. COMMON STOCK
- DR. REDDY'S LABORATORIES LTD COMMON STOCK
- JOHNSON & JOHNSON COMMON STOCK
- NOVARTIS AG COMMON STOCK
- TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES